Fecha: miércoles, 11 de enero de 2017
Dónde:
CNIO - Spanish National Cancer Research Centre
Melchor Fernández Almagro, 3, Madrid
The goal of the workshop is to identify where an IMI programme could bring the most value in moving forward the oncology innovation agenda, taking into consideration the Spanish oncology community and opening a debate around the future.
An strategy for IMI2
Carmen Eibe
Director, Project Coordination Department PharmaMar
The Innovative Medicines Initiative
Pierre Meulien
IMI Executive Director
INB-ISCIII, ELIXIR and Cancer Genomics
Alfonso Valencia
Director Spanish National Bioinformatics Institute (INB)
EU-funded cancer research: towards personalised medicine
Jan-Willem van de Loo
Scientific Officer, Non-communicable diseases and the challenge of healthy ageing, DG Research & Innovation, European Commission
The perspectives of the Spanish Agency of Medicines and Medical Devices
César Hernández García
Head of Department of Medicines for Human Use, Spanish Agency of Medicines and Medical Devices